Improved foot sensitivity and pain, reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy - MIRE
Improved foot sensitivity and pain, reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy - MIRE
复制标题
DOI：
10.1016/j.jdiacomp.2005.06.002
复制
发表时间：
2006-03-01
影响因子：
3
通讯作者：
Burke, TJ
中科院分区：
文献类型：
--
作者：
Harkless, LB;DeLellis, S;Burke, TJ
检查了 2239 名患有周围神经病变 (PN) 的患者（平均年龄 = 73 岁）的病历，以确定 MIRE 治疗实际上是否与脚部对 Semmes Weinstein 单丝 (SWM) 5.07 的敏感性增加和神经性疼痛减轻有关。其中 1395 名患者 (62%) 的 PN 是由糖尿病引起的。在使用 MIRE 治疗之前，在 10 个测试部位（每只脚 5 个）中，有 7.1 +/- 2.9 个部位对 SWM 5.07 不敏感，2078 名患者 (93%) 表现出保护性感觉丧失，医疗保险将其定义为每只脚的两个或多个部位失去感觉。治疗后，双脚无感觉部位减少至2.4+/-2.6个，改善了66%。在 2078 名 (93%) 最初表现出保护性感觉丧失的患者中，1106 名 (53%) 患者在治疗后不再丧失保护性感觉（P
The medical records of 2239 patients (mean age=73 years) with established peripheral neuropathy (PN) were examined to determine whether treatment with MIRE was, in fact, associated with increased foot sensitivity to the Semmes Weinstein monofilament (SWM) 5.07 and a reduction in neuropathic pain. The PN in 1395 of these patients (62%) was due to diabetes. Prior to treatment with MIRE, of the 10 tested sites (5 on each foot), 7.1 +/- 2.9 were insensitive to the SWM 5.07, and 2078 patients (93%) exhibited loss of protective sensation defined by Medicare as a loss of sensation at two or more sites on either foot. After treatment, the number of insensate sites on both feet decreased to 2.4 +/- 2.6, an improvement of 66%. Of the 2078 (93%) patients initially presenting with loss of protective sensation, 1106 (53%) no longer had loss of protective sensation after treatment (P